Amneal
4 products tracked · names used in filings: Amneal, Amneal Pharms Llc, Amneal Pharma Europe Ltd
Upcoming milestones
No upcoming milestones listed.
Recent milestones
Thu 09 Jul 2026🇺🇸 FDA approval
FDA approves Sodium Bicarbonate (sodium bicarbonate): new formulation or manufacturer
Amneal; NDA220790; New formulation or manufacturer; solution · source
Fri 19 Dec 2025🇺🇸 FDA approval
FDA approves biosimilar Boncresa (denosumab-mobz)
Amneal Pharms Llc; BLA761456; Biosimilar; injectable · source
Fri 19 Dec 2025🇺🇸 FDA approval
FDA approves biosimilar Oziltus (denosumab-mobz)
Amneal Pharms Llc; BLA761457; Biosimilar; injectable · source
Products
| Product | Status | Approved | |
|---|---|---|---|
| 🇺🇸 | Sodium Bicarbonate sodium bicarbonate | Approved | 2026-07-09 |
| 🇺🇸 | Boncresa denosumab-mobz | Approved | 2025-12-19 |
| 🇺🇸 | Oziltus denosumab-mobz | Approved | 2025-12-19 |
| 🇪🇺 | Numient levodopa;carbidopa | Withdrawn | 2015-11-19 |
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.